RecruitingNot ApplicableNCT06369857
Pectopexy for Apical Prolapse Management
Pectopexy for Treatment of Apical Pelvic Organ Prolapse
Sponsor
Assiut University
Enrollment
10 participants
Start Date
May 9, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This study was designed to evaluate the efficacy of pectopexy for treatment of apical pelvic organ prolapse at follow up at 12 months. Investigator also evaluates complications, improvement of symptoms, quality-of-life outcomes and patient satisfaction with surgery. Assessment of restoration of normal pelvic anatomy and lower urinary tract symptoms using transperineal ultrasound
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 80 Years
Inclusion Criteria4
- Apical prolapse Stage 2-4 acc. to POP-Q system
- Uterine preservation or after hysterectomy
- Age > 18 years old.
- Sexually active or not.
Exclusion Criteria5
- Pregnancy or up to 6 months postpartum.
- Current Urinary tract infection proved by urine analysis or urine culture.
- Patient unfit for surgery.
- Previous suspension operations.
- Uncontrolled diabetic patients
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREPectopexy
Suspension of apical organs
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06369857
Related Trials
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
NCT0482917510 locations
Centered Surgery - Preoperative Counseling and Patient Satisfaction
NCT074714641 location
GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study
NCT048290583 locations
Vaginal Vault Native Tissue Suspension
NCT075179651 location
Accelerometer Measured Early Recovery After Prolapse Surgery
NCT072180167 locations